The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcomas.
William W. Tseng
No relevant relationships to disclose
Shouhao Zhou
No relevant relationships to disclose
Peter F. Thall
No relevant relationships to disclose
Alexander J. F. Lazar
No relevant relationships to disclose
Raphael E. Pollock
No relevant relationships to disclose
Patrick P. Lin
No relevant relationships to disclose
Janice N. Cormier
No relevant relationships to disclose
Barry W. Feig
No relevant relationships to disclose
Kelly Hunt
No relevant relationships to disclose
Matthew T. Ballo
No relevant relationships to disclose
Shreyaskumar Patel
No relevant relationships to disclose
Peter W. T. Pisters
No relevant relationships to disclose